Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis

Phase 4 Unknown 300 enrolled Centre for Endocrinology and Reproductive Medicine, Italy

RandomizedParallel-groupDouble-blindTreatment

Summary

With this study the investigators want to test which is the best medical treatment for symptomatic adenomyosis affecting women undergoing IVF and with previous implantation failure, between Aromatase inhibitor plus GnRH analog versus GnRH alone, in term pregnancy rate and uterine volume reduction.

Timeline

Start: 2017-12-01
Primary completion: 2024-09-30
Completion: 2024-09-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Anastrozole	Other / unclassified	1 mg	—
Comparator	Leuprolide	Other / unclassified	11.25 mg	—

Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis

Summary

Timeline

Drugs

Indications